Register

COURSE DESCRIPTION:  

Reducing pancreatic enzyme activity in the intestinal lumen below the threshold required for digestive functions is known as exocrine pancreatic insufficiency.  Patients with this disease may present with a variety of clinical manifestations. Quality of life, and other complications related to malnutrition, bone density changes, and increased motility risk are among some of the manifestations of this disease. In this live course, we will identify the etiologies of exocrine pancreatic insufficiency, recognize the symptoms of exocrine pancreatic insufficiency, and explain the impact and consequences of untreated exocrine pancreatic insufficiency. Please join us on this in this informative discussion on this disease. 

TARGET AUDIENCE:

Internal Medicine Physicians, Physician Assistants, Residents, Dentists, Advanced Practice Registered Nurses, Pharmacists and all other interested healthcare providers. 

LEARNING OBJECTIVES:

• Identify the etiologies of exocrine pancreatic insufficiency. 
• Recognize the symptoms of exocrine pancreatic insufficiency. 
• Explain the impact and consequences of untreated exocrine pancreatic insufficiency. 
   

FACULTY AND DISCLOSURES:

Jodie Adam Barkin, M.D.
Assistant Professor of Clinical Medicine
University of Miami, Leonard M. Miller School of Medicine
Department of Medicine, Division of Gastroenterology

Jodie Barkin, M.D., faculty for this educational activity, is a consultant for AbbVie, Nestle Health Sciences, HealthiVibe/CorEvitas, Envara Health and Medtronics. He also receives Unrestricted Educational Grants (Prior) from AbbVie, Cook Endoscopy and Career Development Grant: Cystic Fibrosis Foundation DIGEST Grant. Dr. Barkin has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.

John Rubin, M.D., director for this educational event, owns stock in AstraZeneca and Bristol Myers Squibb. He has indicated that the presentation or discussion will not include off-label or unapproved product usage. All of the relevant financial relationships listed for this individual have been mitigated.  

Kenneth Rosenthal, M.D., FACG, moderator for this educational event, indicated that he is on the Speaker’s Bureau for AbbVie, Inc. All of the relevant financial relationships listed for this individual has been mitigated. 

Non-faculty contributors and others involved in the planning, development and editing/review of the content have no relevant financial relationships to disclose with ineligible companies.*

*Ineligible companies – Companies whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients.
 

Disclosure Policy and Disclaimer

ACCREDITATION STATEMENTS AND CREDITS

Baptist Health South Florida is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Baptist Health South Florida designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.  Physicians should claim only the credit commensurate with the extent of their participation in the activity.   

This activity has been approved for 1 credit hour, CE Broker Course #20-855339, by the Florida Boards of Medicine, Podiatry, Dentistry, Osteopathic Medicine and Physician Assistants.  

This activity has also been approved for 1 credit for Nurse Practitioners, Nurses, Pharmacists and Pharmacy Techs, Athletic Trainers. Baptist Health South Florida CE Broker Provider #50-182.